500
Participants
Start Date
March 21, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
July 31, 2026
ProtEmbo - Cerebral Embolic Protection
Subjects will undergo TAVR following placement of the ProtEmbo cerebral embolic protection device.
Sentinel - Cerebral Embolic Protection
Subjects will undergo TAVR following placement of the Sentinel cerebral embolic protection device.
RECRUITING
NYU Langone, New York
RECRUITING
Mount Sinai Hospital, New York
RECRUITING
Columbia University Medical Center / NYPH, New York
RECRUITING
Weill Medical College / Cornell University, New York
RECRUITING
State University of New York at Buffalo, Buffalo
RECRUITING
University of Virginia, Charlottesville, Charlottesville
RECRUITING
Lübeck Universitätsklinikum Schleswig-Holstein Campus, Lübeck
RECRUITING
BayCare Health System / Morton Plant Hospital, Clearwater
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Medical College of Wisconsin, Milwaukee
RECRUITING
Trier Krankenhaus der Barmherzigen Brüder, Trier
RECRUITING
Washington University - St. Louis, St Louis
RECRUITING
Saint Luke's Hospital of Kansas City, Kansas City
RECRUITING
University of Texas, Memorial Hermann Hospital, Houston
RECRUITING
Tucson Medical Center Health, Tucson
RECRUITING
Ulm Universitätsklinikum, Ulm
RECRUITING
Cedars-Sinai Medical Center, Los Angeles
RECRUITING
Morristown Medical Center, Morristown
RECRUITING
Dresden Herzzentrum, Dresden
RECRUITING
Gdansk Uniwersyteckie Centrum Kliniczne, Gdansk
Protembis GmbH
INDUSTRY